RxDoctor Payments Data

Joshua Ruedisueli, PA

Physician Assistant · Southfield, MINPI 1326425851

Payments from drug & device makers

$523in general payments, 2019–2025

Across 18 payments — averaging $29.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$175
  • Cardiovascular Systems Inc.$112
  • Boehringer Ingelheim$67
  • AbbVie$40
  • Biomerieux Inc$27
  • AstraZeneca$24
  • plus $78 from 4 others

What the payments were for

  • Food & beverage$523100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$523 in reported general payments places this provider in the 65th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$7,490
Medicare patients
42
Services billed
148

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$12,965
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$2,649
Ventolin HfaAlbuterol Sulfate13$706
Albuterol Sulfate HfaAlbuterol Sulfate15$426
Levothyroxine Sodium23$352
Cephalexin20$344
Atorvastatin Calcium30$242
Tamsulosin Hcl13$222
Prednisone26$162
Gabapentin20$137
Lisinopril22$115
Omeprazole11$104
Metformin Hcl18$89
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$77
Azithromycin17$69

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$175$12,96517 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Southfield

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →